
Loading, please wait...

Loading, please wait...

Layered bismuth-based materials are emerging as powerful tools in modern medicine. These materials possess unique structural chemistry and versatile physicochemical properties. Furthermore, their tailorable nature makes them ideal for diverse biomedical applications. Researchers can now modulate these compounds at the atomic scale. Consequently, this allows for precise control over electronic bandgaps and polarization. Such structural engineering creates new opportunities for Indian clinicians in diagnostics and therapeutics.
Modern radiology benefits significantly from these material advancements. Specifically, bismuth offers a high atomic number that enables superior X-ray attenuation. Therefore, these materials serve as highly effective contrast agents for CT scans. Moreover, they provide a safer, non-toxic alternative to traditional lead-based technologies. Additionally, layered bismuth-based materials enhance the sensitivity of next-generation imaging sensors. This improvement allows for lower radiation doses during routine diagnostic procedures.
In addition to diagnostics, these materials transform modern cancer treatment. They exhibit excellent photothermal conversion efficiency under near-infrared light. This unique property allows for highly targeted ablation therapy in oncology. Furthermore, researchers utilize their large surface areas for efficient drug delivery systems. Consequently, this improves therapeutic efficacy while reducing systemic toxicity in patients. High-performance biosensors also rely on these materials to detect biomarkers with extreme precision. In summary, these compounds represent a major step forward for integrated biomedical systems.
The transition from laboratory research to clinical practice faces several technical challenges. However, the future of these materials remains extremely promising. Clinicians should monitor these developments closely as they mature. They will likely redefine imaging protocols and therapeutic strategies in the coming years. Ongoing research continues to refine their biocompatibility for long-term clinical use.
These materials have a high atomic number, which provides excellent X-ray attenuation. They are also generally considered less toxic than lead-based contrast agents.
They are used in photothermal therapy to convert light into heat, which destroys cancer cells. Additionally, they serve as efficient carriers for targeted drug delivery.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Xie H et al. Tailoring of Layered Bismuth-Based Materials: Advanced Functionalities for Environment, Energy, Photonics, Electronics, and Biomedicine. Adv Mater. 2026 May 27. doi: 10.1002/adma.73398. PMID: 42200348.
Shah Noor et al. Recent advances in bismuth-based heterojunction photocatalysts. Front Chem. 2026 Mar 19;14:1753678. doi: 10.3389/fchem.2026.1753678. PMID: 41970236.
Ghosh J, Hoye RLZ. Progress and opportunities in bismuth-based materials for X-ray detection. MRS Energy Sustain. 2025 Aug 25;12:233.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A comprehensive review of layered bismuth-based materials and their revolutionary impact on medical imaging, oncology, and next-generation biosensing....
4 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday